- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-01-0005921

Arrier Biotech Private Limited
About Arrier Biotech Private Limited
Data last updated:
Arrier Biotech Private Limited is a private limited company based in Ambala, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24290HR2021PTC092271. Its GSTIN is 06AAUCA6585H1Z2 (Haryana).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anuradha and Ranjan Dhingra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at # 396 Sector – 9, Ambala, Haryana, India – 134003.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.36 Cr, a growth of 40% compared to the previous year. For the same year it recorded a net profit of ₹31.86 Lakh (net margin 4.3%) and EBITDA of ₹47.08 Lakh (EBITDA margin 6.4%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years.
As per MCA filings, the company has satisfied charges of ₹30 Lakh on record.
Arrier Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-01-0005921).
Company details
Recognitions & Rankings of Arrier Biotech
Contact details
Arrier Biotech Private Limited's registered office is in Ambala, Haryana.
- Registered Address# 396 Sector – 9, Ambala, Haryana, India – 134003
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Arrier Biotech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Arrier Biotech Private Limited, buy the company report.
Financials of Arrier Biotech Private Limited
FY 2025 filings availableArrier Biotech Private Limited reported revenue of ₹7.36 Cr (up 40% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 38% over three years, including 40% growth in the latest year. EBITDA rose 145% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹47.08 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹31.86 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.4% | ||||
| Net Profit Margin | 4.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Arrier Biotech Private Limited, buy the company report.
Board of directors of Arrier Biotech Private Limited
Arrier Biotech has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anuradha | Director | 18 Jan 2021 | 5 Years 9 Months | Current |
| Ranjan Dhingra Also directs: Ranofy Biotech Private Limited | Director | 18 Jan 2021 | 5 Years 9 Months | Current |
Peer comparison
Arrier Biotech Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Winnexa Health Sciences Private Limited | ₹7.38 Cr (FY 2025) | 115.0% | Indore, Madhya Pradesh, India | |||
| Immugen Lifesciences Private Limited | ₹7.38 Cr (FY 2023) | -25.0% | Nagpur, Maharashtra, India | |||
| Navodaya Pharmaceuticals Private Limited | ₹7.38 Cr (FY 2024) | -19.0% | Noida, Uttar Pradesh, India | |||
| Arrier Biotech Private Limitedthis company | ₹7.36 Cr (FY 2025) | ₹31.86 Lakh | 4.3% | 40.0% | Ambala, Haryana, India | |
| Prime Time Logistics Technologies Private Limited | ₹7.33 Cr (FY 2025) | 29.0% | Hyderabad, Telangana, India | |||
| Dey's Medico Pvt Ltd | ₹7.32 Cr (FY 2024) | 3.0% | West Bengal, India | |||
| Oldmed Healthcare Private Limited | ₹7.32 Cr (FY 2024) | 50.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Arrier Biotech Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Oct 2023 | 100866446 | Others | ₹30 Lakh | Satisfied |
To see the full charge records of Arrier Biotech Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Arrier Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Arrier Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Arrier Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAUCA6585H1Z2 | Haryana | Active | 17 Feb 2021 |
To see the full GST registrations and return filing status of Arrier Biotech Private Limited, buy the company report.
Recent activity
Arrier Biotech Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Anuradha was appointed as Director on 18 Jan 2021.
Frequently asked questions
Arrier Biotech is an active private limited company based in Ambala, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 January 2021 (5+ years old) and is registered under CIN U24290HR2021PTC092271.
Arrier Biotech has 2 current directors:
- Anuradha - Director
- Ranjan Dhingra - Director
The latest financial statements of Arrier Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Arrier Biotech is 06AAUCA6585H1Z2, registered in Haryana.
The CIN (Corporate Identification Number) of Arrier Biotech is U24290HR2021PTC092271. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Arrier Biotech was incorporated on 18 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Arrier Biotech by revenue are Winnexa Health Sciences Private Limited, Immugen Lifesciences Private Limited, Navodaya Pharmaceuticals Private Limited, Prime Time Logistics Technologies Private Limited, Dey's Medico Pvt Ltd and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Anuradha was appointed as Director on 18 Jan 2021. Ranjan Dhingra was appointed as Director on 18 Jan 2021.
Yes, Arrier Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-01-0005921).
The registered office of Arrier Biotech is at # 396 Sector – 9, Ambala, Haryana, India – 134003.
Arrier Biotech operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

